Stock Report

All about this stock under one free report Last Updated: 08-Oct-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Q-Line Biotech Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: QLINE

₹655.75

up-down-arrow ₹-28.60 (-4.18%)

As on 08-Oct-2026 15:50IST

Market cap

info icon

₹1,596 Cr

Revenue (TTM)

info icon

₹342 Cr

P/E Ratio

info icon

28.7

P/B Ratio

info icon

3.3

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 9.13 23.20 --
EBIT -- -- 59.88 40.30 --
Net Profit -- -- 255.32 37.61 --
EPS -- -- 180.69 18.88 --
Book Value -- -- 25.43 23.21 --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-26Mar-25Mar-24
EBIT-Margin info 19.92--25.5517.4416.76
Net Margin info 10.45--16.044.8210.48
Return on equity info 16.48--25.558.9214.97
Return on Capital info 18.15--22.2316.1716.07
Return on Assets info 7.44--11.013.957.34
Debt to Equity (x) info ----0.920.880.60

Profitability

View Detailed Peer Comparison

ROCE

22.23

Higher than Peers by 8.18

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
22.23
16.17
16.07
16.76
--
Peer Median
14.05
13.23
16.51
17.42
--
ROE

25.55

Higher than Peers by 14.61

Profit after tax / Average Net worth * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
25.55
8.92
14.97
16.79
--
Peer Median
10.94
14.03
12.58
14.29
--
ROA

11.01

Higher than Peers by 3.96

Profit after tax / Average Total assets * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
11.01
3.95
7.34
8.52
--
Peer Median
7.05
6.05
6.27
11.08
--
EBIT Margin

25.55

Higher than Peers by 8.87

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
25.55
17.44
16.76
17.30
--
Peer Median
16.68
11.92
17.72
10.64
--
Net Margin

16.04

Higher than Peers by 6.82

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
16.04
4.82
10.48
11.57
--
Peer Median
9.22
6.31
8.62
8.68
--
Cash Profit Margin

18.40

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
18.40
7.25
12.56
12.87
--
Peer Median
--
--
0.00
0.00
--

Growth

View Detailed Peer Comparison

Revenue Growth

9.13

Lower than Peers by 33.35

Year on year growth in net sales

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
9.13
53.77
11.44
--
--
Peer Median
42.49
19.29
35.34
69.01
--
EBIT Growth

59.88

Lower than Peers by 66.20

Year on year growth in operating profit (EBIT)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
59.88
59.97
7.97
--
--
Peer Median
126.08
21.41
45.38
4,139.53
--
Net Profit Growth

255.32

Lower than Peers by 2,16,644.68

Year on year growth in profit after tax

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
255.32
-27.54
1.21
--
--
Peer Median
2,16,900.00
147.16
65.85
686.54
--
EPS Growth

180.69

Lower than Peers by 2,18,420.46

Year on year growth in earnings per share

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
180.69
-44.23
7.33
--
--
Peer Median
2,18,601.15
147.16
--
--
--
Book Value Growth

29.61

--

Year on year growth in book value per share

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
29.61
17.39
27.05
--
--
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.92

Higher than Peers by 0.66

Total debt / Net worth

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
0.92
0.88
0.60
0.58
--
Peer Median
0.25
0.32
0.48
0.12
--
Short term debt to equity ratio

0.36

--

(Short term borrowings / Net worth)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
0.36
0.29
0.31
0.43
--
Peer Median
--
--
--
--
--
Current Ratio

1.64

Lower than Peers by 0.98

Current Assets / Current Liabilities and Provisions

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
1.64
1.48
1.42
1.63
--
Peer Median
2.62
2.55
1.90
1.53
--
Quick Ratio

1.19

Lower than Peers by 3.69

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
1.19
0.97
0.67
1.23
--
Peer Median
4.88
12.10
1.77
2.22
--
Interest Coverage

4.73

Lower than Peers by 0.15

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
4.73
3.32
5.83
8.75
--
Peer Median
4.88
4.04
4.81
6.93
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

36.82

Higher than Peers by 0.08

Debtors outstanding / Net Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
36.82
26.38
12.99
18.09
--
Peer Median
36.74
24.00
33.89
21.39
--
Asset Turnover

0.71

Lower than Peers by 0.37

Sales / Average Total Assets

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
0.71
0.79
0.69
0.73
--
Peer Median
1.08
0.94
1.29
0.86
--
Receivable days

105.22

--

Average Debtors / Sales * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
105.22
63.55
53.32
66.03
--
Peer Median
--
--
--
--
--
Inventory Days

93.48

--

Average Inventory / Sales * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
93.48
113.91
133.38
87.08
--
Peer Median
--
--
--
--
--
Payable days

146.52

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
146.52
143.30
194.12
163.82
--
Peer Median
--
--
--
--
--
Cash Conversion Cycle

52.17

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
52.17
34.16
-7.42
-10.72
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
--
--
--
--
--
Peer Median
51.96
20.16
51.65
61.00
--
Price / Book Value

--

--

Current share price divided by book value per share in the latest financial year

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
--
--
--
--
--
Peer Median
6.30
2.28
3.04
6.15
--
EV/EBITDA

1.59

Lower than Peers by 19.37

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
1.59
1.64
1.68
-0.41
--
Peer Median
20.96
14.45
25.55
11.25
--
Market Cap

--

--

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Q-Line Biotech
--
--
--
--
--
Peer Median
317
252
126
36
--
loading...
loading...
loading...
loading...